These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 16319256)

  • 1. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
    Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
    Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial stromal sarcoma: analysis of treatment failures and survival.
    Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
    Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
    Weitmann HD; Kucera H; Knocke TH; Pötter R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.
    Shah JP; Bryant CS; Kumar S; Ali-Fehmi R; Malone JM; Morris RT
    Obstet Gynecol; 2008 Nov; 112(5):1102-8. PubMed ID: 18978112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-institutional review of outcomes of endometrial stromal sarcoma.
    Leath CA; Huh WK; Hyde J; Cohn DE; Resnick KE; Taylor NP; Powell MA; Mutch DG; Bradley WH; Geller MA; Argenta PA; Gold MA
    Gynecol Oncol; 2007 Jun; 105(3):630-4. PubMed ID: 17320937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
    Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT
    Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian preservation and staging in reproductive-age endometrial cancer patients.
    Richter CE; Qian B; Martel M; Yu H; Azodi M; Rutherford TJ; Schwartz PE
    Gynecol Oncol; 2009 Jul; 114(1):99-104. PubMed ID: 19410280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of ovarian preservation in premenopausal women with endometrial cancer.
    Wright JD; Buck AM; Shah M; Burke WM; Schiff PB; Herzog TJ
    J Clin Oncol; 2009 Mar; 27(8):1214-9. PubMed ID: 19171707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue.
    Burke C; Hickey K
    Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1182-4. PubMed ID: 15516445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial stromal sarcoma: a population-based analysis.
    Chan JK; Kawar NM; Shin JY; Osann K; Chen LM; Powell CB; Kapp DS
    Br J Cancer; 2008 Oct; 99(8):1210-5. PubMed ID: 18813312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
    Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
    Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
    Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.